Gul Majid Khan

Prof. Dr. Gul Majid Khan

Quaid-i-Azam University Islamabad

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2016 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
FRFiza Ur Rehman
Fiza Ur Rehman
KSKifayat Ullah Shah
Kifayat Ullah Shah
SSShefaat Ullah Shah
Shefaat Ullah Shah
IKIkram Ullah Khan
Ikram Ullah Khan
Gul Majid KhanGul Majid Khan
Gul Majid Khan
Amjad KhanAmjad Khan
Amjad Khan
Lipid-based drug delivery systems (LBDDS) are the most promising technique to formulate the poorly water soluble drugs. Nanotechnology strongly influences the therapeutic performance of hydrophobic drugs and has become an essential approach in drug delivery research. Self-nanoemulsifying drug delivery systems (SNEDDS) are a vital strategy that combines benefits of LBDDS and nanotechnology. SNEDDS are now preferred to improve the formulation of drugs with poor aqueous solubility. Areas covered: The review in its first part shortly describes the LBDDS, nanoemulsions and clarifies the ambiguity between nanoemulsions and microemulsions. In the second part, the review discusses SNEDDS and elaborates on the current developments and modifications in this area without discussing their associated preparation techniques and excipient properties. Expert opinion: SNEDDS have exhibit the potential to increase the bioavailability of poorly water soluble drugs. The stability of SNEDDS is further increased by solidification. Controlled release and supersaturation can be achieved, and are associated with increased patient compliance and improved drug loads, respectively. Presence of biodegradable ingredients and ease of large-scale manufacturing combined with a lot of 'drug-targeting opportunities' give SNEDDS a clear distinction and prominence over other solubility enhancement techniques.

24 May 2019 in Medicina
Verified
Journal Article
Open access
PDF file
JBJeand Baloch
Jeand Baloch
MSMuhammad Farhan Sohail
Muhammad Farhan Sohail
SSshoaib soaib
shoaib soaib
MKMaria Kiani
Maria Kiani
Gul Majid KhanGul Majid Khan
Gul Majid Khan
Gul ShahnazGul Shahnaz
Gul Shahnaz
Background and Objectives: Lipid-based self-nanoemulsifying drug delivery systems (SNEDDS) have resurged the eminence of nanoemulsions by modest adjustments and offer many valuable opportunities in drug delivery. Chlorpromazine, an antipsychotic agent with poor aqueous solubility—with extensive first-pass metabolism—can be a suitable candidate for the development of SNEDDS. The current study was designed to develop triglyceride-based SNEDDS of chlorpromazine to achieve improved solubility, stability, and oral bioavailability. Materials and Methods: Fifteen SNEDDS formulations of each short, medium, and long chain, triglycerides were synthesized and characterized to achieve optimized formulation. The optimized formulation was characterized for several in vitro and in vivo parameters. Results: Particle size, zeta potential, and drug loading of the optimized SNEDDS (LCT14) were found to be 178 ± 16, −21.4, and 85.5%, respectively. Long chain triglyceride (LCT14) showed a 1.5-fold increased elimination half-life (p < 0.01), up to 6-fold increased oral bioavailability, and 1.7-fold decreased plasma clearance rate (p < 0.01) compared to a drug suspension. Conclusion: The findings suggest that SNEDDS based on long-chain triglycerides (LCT14) formulations seem to be a promising alternative for improving the oral bioavailability of chlorpromazine.

17 August 2017 in Discover Nano
Verified
Journal Article
Open access
PDF file
MMMaria Mir
Maria Mir
SISaba Ishtiaq
Saba Ishtiaq
SRSamreen Rabia
Samreen Rabia
MKMaryam Khatoon
Maryam Khatoon
AZAhmad Zeb
Ahmad Zeb
FUFakhar Ud-din
Fakhar Ud-din
Science and technology have always been the vitals of human’s struggle, utilized exclusively for the development of novel tools and products, ranging from micro- to nanosize. Nanotechnology has gained significant attention due to its extensive applications in biomedicine, particularly related to bio imaging and drug delivery. Various nanodevices and nanomaterials have been developed for the diagnosis and treatment of different diseases. Herein, we have described two primary aspects of the nanomedicine, i.e., in vivo imaging and drug delivery, highlighting the recent advancements and future explorations. Tremendous advancements in the nanotechnology tools for the imaging, particularly of the cancer cells, have recently been observed. Nanoparticles offer a suitable medium to carryout molecular level modifications including the site-specific imaging and targeting. Invention of radionuclides, quantum dots, magnetic nanoparticles, and carbon nanotubes and use of gold nanoparticles in biosensors have revolutionized the field of imaging, resulting in easy understanding of the pathophysiology of disease, improved ability to diagnose and enhanced therapeutic delivery. This high specificity and selectivity of the nanomedicine is important, and thus, the recent advancements in this field need to be understood for a better today and a more prosperous future.

1 January 2018 in Drug Delivery
Verified
Journal Article
Open access
MDM. Junaid Dar
M. Junaid Dar
FUFakhar Ud-din
Fakhar Ud-din
Gul Majid KhanGul Majid Khan
Gul Majid Khan
Topical drug delivery against cutaneous leishmaniasis (CL) signifies an effective alternate for improving the availability and reducing the toxicity associated with the parenteral administration of conventional sodium stibogluconate (SSG) injection. The basic aim of the study was to develop nano-deformable liposomes (NDLs) for the dermal delivery of SSG against CL. NDLs were formulated by a modified thin film hydration method and optimized via Box–Behnken statistical design. The physicochemical properties of SSG-NDLs were established in terms of vesicle size (195.1 nm), polydispersity index (0.158), zeta potential (−32.8 mV), and entrapment efficiency (35.26%). Moreover, deformability index, in vitro release, and macrophage uptake studies were also accomplished. SSG-NDLs were entrapped within Carbopol gel network for the ease of skin application. The ex vivo skin permeation study revealed that SSG-NDLs gel provided 10-fold higher skin retention towards the deeper skin layers, attained without use of classical permeation enhancers. Moreover, in vivo skin irritation and histopathological studies verified safety of the topically applied formulation. Interestingly, the cytotoxic potential of SSG-NDLs (1.3 mg/ml) was higher than plain SSG (1.65 mg/ml). The anti-leishmanial activity on intramacrophage amastigote model of Leishmania tropica showed that IC50 value of the SSG-NDLs was ∼ fourfold lower than the plain drug solution with marked increase in the selectivity index. The in vivo results displayed higher anti-leishmanial activity by efficiently healing lesion and successfully reducing parasite burden. Concisely, the outcomes indicated that the targeted delivery of SSG could be accomplished by using topically applied NDLs for the effective treatment of CL.

1 September 2016 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
QKQudrat Ullah Khan
Qudrat Ullah Khan
QYQipeng Yuan
Qipeng Yuan
YWYun Wei
Yun Wei
Gul Majid KhanGul Majid Khan
Gul Majid Khan
ZKZia Ul Haq Khan
Zia Ul Haq Khan
FKFaheem Ullah Khan
Faheem Ullah Khan

1 August 2016 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
AAAftab Ahmad
Aftab Ahmad
YWYun Wei
Yun Wei
FSFatima Syed
Fatima Syed
SKShafiullah Khan
Shafiullah Khan
Gul Majid KhanGul Majid Khan
Gul Majid Khan
QYQipeng Yuan
Qipeng Yuan